Cost-utility analysis of transdiagnostic cognitive behavioural therapy for people with persistent physical symptoms in contact with specialist services evaluated in the PRINCE secondary trial
Adding TDT-CTB to SMC results in slightly increased costs and slightly better outcomes in terms of QALYs. This represents a cost-effective option based on the conventional QALY threshold value.
Authors
- Matthew H. Hotopf (ORCID: https://orcid.org/0000-0002-3980-4466)
- Rona Moss‐Morris (ORCID: https://orcid.org/0000-0002-2927-3446)
- Anthony S. David (ORCID: https://orcid.org/0000-0003-0967-774X)
- Meenal Patel (ORCID: https://orcid.org/0000-0001-9646-3314)
- Sabine Landau (ORCID: https://orcid.org/0000-0002-3615-8075)
- Trudie Chalder (ORCID: https://orcid.org/0000-0003-0775-1045)
- Mujtaba Husain (ORCID: https://orcid.org/0000-0003-0273-7199)
- Paul McCrone (ORCID: https://orcid.org/0000-0001-7001-4502)
- Kirsty James (ORCID: https://orcid.org/0000-0002-2657-8148)
- Mark J. Ashworth (ORCID: https://orcid.org/0000-0001-6514-9904)
Institutions
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
Publication Details
- Journal
- Journal of Psychosomatic Research
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1016/j.jpsychores.2024.111960
- Citations
- 2
- Primary Topic
- Psychosomatic Disorders and Their Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- European Committee for Treatment and Research in Multiple Sclerosis
- Wellcome Trust
- National Institute for Health and Care Research
- Parkinson's UK
- King's College London
- Medical Research Council
- Economic and Social Research Council